GLP-1R and GIPR Cell-Based Reporter Assays: New Tools to Advance the Development of Therapeutics for Type II Diabetes and Obesity!

In this poster presented at Discovery on Target 2024, discover how the utilization of these robust assays can improve the workflow and decrease time to data for the development of novel therapies and biosimilars to treat T2D and obesity.

Are you ready to revolutionize your metabolic research? Our GLP-1R and GIPR reporter assays offer a fast, reliable solution to drug discovery challenges in type II diabetes and obesity. Get exclusive access to our latest scientific poster and see how these assays can streamline your workflow and deliver reproducible, actionable data in record time.

Download the Poster to Learn:

• How our human and murine GLP-1R and GIPR assays enable precise characterization of drug compounds.
• The benefits of minimal lot-to-lot variability for reliable and reproducible results.
• How all-inclusive assay kits simplify your research and speed up data acquisition in just 24 hours.